Naltrexone implant helps HIV patients with opioid dependence prevent relapse
(University of Pennsylvania School of Medicine) A new study, published this month in Lancet HIV by Penn Medicine researchers, shows that a naltrexone implant placed under the skin was more effective at helping HIV-positive patients with an opioid addiction reduce relapse and have better HIV-related outcomes compared to the oral drug.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Addiction | International Medicine & Public Health | Skin | Study | University of Pennsylvania